|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Sep―06 |
Salivary antiviral and antibacterial properties in the encounter of SARS-CoV-2 |
Nooshin Mohtasham, Rahimeh Bargi, Alieh Farshbaf, Maryam Vahabzadeh Shahri, Kiana Kamyab Hesari, Farnaz Mohajertehran |
2 |
[GO] |
2023―Aug―16 |
Acute Kidney Injury (AKI) in COVID-19: In silico Identification of LncRNA-MiRNA-Gene Networks and Key Transcription Factors |
Somayeh Hashemi Sheikhshabani, Zeinab Amini-Farsani, Nesa Kazemifard, Parastoo Modarres, Sharareh Khazaei Feyzabad, Zahra Amini-Farsani, et al. (+3) Nasibeh Shaygan, Mir Davood Omrani, Soudeh Ghafouri-Fard |
3 |
[GO] |
2023―Jul―30 |
Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19 |
|
4 |
[GO] |
2023―Jul―30 |
Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp |
|
5 |
[GO] |
2023―May―17 |
Electroacupuncture in Regulating Gastrointestinal Symptoms of COVID-19: A
Mini-review |
Xianqiang Yu, Yingjie Wang |
6 |
[GO] |
2023―May―11 |
Exploring the potential mechanism of action of ursolic acid against gastric cancer and COVID-19 using network pharmacology and bioinformatics analysis |
Hailiang Huang, Zhiyao Liu, Ying Yu, Yuqi Jia, Lingling Li, Xin Shi, Fangqi Wang |
7 |
[GO] |
2023―Jan―03 |
Experimental and Computational Approaches for SARS-CoV-2 Theranostics |
Ijaz Gul, Mohammad Amjad Kamal |
8 |
[GO] |
2022―Dec―21 |
In-Silico Study of Resveratrol as Multi-Edged Potent Inhibitor against SARS-Cov-2 and Variants of Concern Using Molecular Dynamic Simulation and PCA Analysis |
Amaresh Kumar Sahoo, Vishal Singh, Vidhu Agarwal, Pritish Kumar Varadwaj |
9 |
[GO] |
2022―Dec―07 |
Therapeutic Applications of Fucoidans and their Potential to Act against COVID-19 |
Dhananjay Yadav, Minseok Song |
10 |
[GO] |
2022―Dec―06 |
In Silico Studies Reveal Antiviral Effects of Traditional Indian Spices on COVID-19 |
Brijesh Kumar |
11 |
[GO] |
2022―Dec―06 |
Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19) |
Evellyn Claudia Wietzikoski Lovato |
12 |
[GO] |
2022―Dec―06 |
Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19 |
Shadma Wahab |
13 |
[GO] |
2022―Dec―06 |
Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19 |
Yasanandana S. Wijayasinghe |
14 |
[GO] |
2022―Dec―06 |
Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19 |
Md. Tabish Rehman |
15 |
[GO] |
2022―Dec―06 |
Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective |
Freah Alshammary |
16 |
[GO] |
2022―Dec―06 |
COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2 |
Rajesh Kumar |
17 |
[GO] |
2022―Dec―06 |
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments |
Clodoveo Ferri |
18 |
[GO] |
2022―Dec―06 |
The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic |
Marina Darenskaya |
19 |
[GO] |
2022―Dec―06 |
Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients |
Kholoud F. Aliter |
20 |
[GO] |
2022―Dec―06 |
Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations |
Urooj Fatima |
21 |
[GO] |
2022―Dec―06 |
COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus |
Shima Tavakol |
22 |
[GO] |
2022―Dec―06 |
Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management |
Hussien Ahmed H. Abdelgawad |
23 |
[GO] |
2022―Dec―06 |
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
Khojasteh Malekmohammad |
24 |
[GO] |
2022―Dec―06 |
miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis |
Rohit Satyam |
25 |
[GO] |
2022―Dec―06 |
Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm |
Monireh Torabi-Rahvar |
26 |
[GO] |
2022―Dec―06 |
Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections |
Arquimedes Gasparotto Junior |
27 |
[GO] |
2022―Nov―24 |
Host-Cell Surface Binding Targets in
SARS-COV-2 for Drug Design |
Sayyed Abbas Tabatabai, Hanieh Maleksabet, Elham Rezaee |
28 |
[GO] |
2022―Nov―08 |
Current insights and molecular docking studies of the drugs under clinical trial as rdrp inhibitors in COVID-19 treatment |
Amita Verma, Pradeep Kumar, Irine Pauly, Ankit Kumar Singh, Adarsh Kumar, Yogesh Singh, et al. (+2) Suresh Thareja, Mohammad A. Kamal |
29 |
[GO] |
2022―Oct―28 |
Mast Cell's Role in Cytokine Release Syndrome and Related Manifestations of COVID-19 Disease |
Öner Özdemir, Azize Yasemin Göksu Erol, Ümmügülsüm Dikici |
30 |
[GO] |
2022―Oct―26 |
Nitric oxide and its derivatives containing nasal spray and inhalation therapy for the treatment of COVID-19 |
Vivek P Chavda, Lalitkumar K Vora, Rajeev K. Singla, Aayushi B. Patel, Priyal Shah, Vladimir N. Uversky, Vasso Apostolopoulos |
31 |
[GO] |
2022―Oct―21 |
Vaccination against SARS-CoV-2 protects from COVID-19-induced endothelial dysfunction |
Evangelos Oikonomou, Stamatios Lampsas, Nektarios Souvaliotis, Savvas Sarantos, Gerasimos Siasos, Garyphallia Poulakou, et al. (+10) Thekla Lytra, Georgios Angelos Papamikroulis, Nikolaos Fountoulakis, Panagiotis Theofilis, Dimitris Tousoulis, Manolis Vavuranakis, Aikaterini Tsatsaragkou, Georgios Marinos, Dimitris Tousoulis, Manolis Vavuranakis |
32 |
[GO] |
2022―Oct―20 |
State-of-the-art tools to elucidate the therapeutic potential of TAT-peptide (TP) conjugated repurposing drug against SARS-CoV-2 spike glycoproteins |
Mohammad Azam Ansari, Mohammad N. Alomary, Qazi Mohammad Sajid Jamal, Yosif Almoshari, Ahmed Salawi, Suliman A. Alhmahmoud, Johra Khan |
33 |
[GO] |
2022―Oct―18 |
Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19 |
Shadma Wahab |
34 |
[GO] |
2022―Oct―18 |
COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy |
Md. Rahman |
35 |
[GO] |
2022―Oct―18 |
COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus |
Shima Tavakol |
36 |
[GO] |
2022―Sep―27 |
Clinical Consideration for Mesenchymal Stem Cells in Treatment of COVID-19 |
Kang-Hsi Wu, Yu-Hua Chao, Te-Fu Weng, Ju-Pi Li |
37 |
[GO] |
2022―Sep―09 |
Tetraspanin-enriched Microdomain Containing CD151, CD9, and TSPAN 8 -
Potential Mediators of Entry and Exit Mechanisms in Respiratory Viruses Including
SARS-CoV-2 |
RamaRao Malla, Mohammad Amjad Kamal |
38 |
[GO] |
2022―Aug―02 |
Herbal medicines as potential inhibitors of SARS-CoV-2 infection |
Soodabeh Rostami, Shima Gharibi, Hajar Yaghoobi, Zary Nokhodian, Parisa Shoaei, Armina Alaghband Bahrami, et al. (+2) Shahrzad Ahangarzadeh, Abbas Alibakhshi |
39 |
[GO] |
2022―Aug―01 |
COVID-19: Pathophysiology, transmission, and drug development for therapeutic treatment and vaccination strategies |
Vishal Kumar Singh, Himani Chaurasia, Richa Mishra, Ritika Srivastava, Aditya K. Yadav, Jayati Dwivedi, et al. (+2) Prashant Singh, Ramendra K. Singh |
40 |
[GO] |
2022―Jul―22 |
Cytokine Release Syndrome in Pathogenesis and Treatment of COVID-19 |
Tao Hu, Chi Hin Cho |
41 |
[GO] |
2022―Jul―22 |
An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects |
Maryam Jamshidnia, Robert D. E. Sewell, Mahmoud Rafieian-Kopaei |
42 |
[GO] |
2022―Jul―17 |
Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections |
Gasparotto A. |
43 |
[GO] |
2022―Jul―14 |
A review of current evidence from cardiovascular manifestations and outcomes in patients with COVID-19 |
Shirin Saberianpour, Elahe Aleebrahim-Dehkordi, Elaheh Mazaheri, Ali Hasanpour-Dehkordi |
44 |
[GO] |
2022―Jul―14 |
Prolonged NHE Activation may be Both Cause and Outcome of Cytokine Release Syndrome in COVID-19 |
Medine Cumhur Cure, Erkan Cure |
45 |
[GO] |
2022―Jul―14 |
Therapeutic potential of P2X7 purinergic receptor modulation in the main organs affected by the COVID-19 cytokine storm |
Júlia Leão Batista Simões, Leilane Dayane Sobierai, Stefany Maciel Pereira, Miriam Vitória Rodrigues dos Santos, Margarete Dulce Bagatini |
46 |
[GO] |
2022―Jul―04 |
COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants |
Ruchika Yogesh, Noopur Srivastava, Syed Nasir Abbas Bukhari |
47 |
[GO] |
2022―Jun―21 |
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies |
Clodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, Dilia Giuggioli, Lorenzo Dagna, Antonio Tavoni, et al. (+78) Francesco Ursini, Massimo L'Andolina, Francesco Caso, Ruscitti Piero, Maurizio Caminiti, Rosario Foti, Valeria Riccieri, Serena Guiducci, Roberta Pellegrini, Elisabetta Zanatta, Giuseppe Varcasia, Domenico Olivo, Pietro Gigliotti, Giovanna Cuomo, Giuseppe Murdaca, Riccardo Cecchetti, Rossella De Angelis, Nicoletta Romeo, Francesca Ingegnoli, Franco Cozzi, Veronica Codullo, Ilaria Cavazzana, Michele Colaci, Giuseppina Abignano, Maria De Santis, Ennio Lubrano, Enrico Fusaro, Amelia Spinella, Federica Lumetti, Giacomo De Luca, Silvia Bellando-Randone, Elisa Visalli, Ylenia Dal Bosco, Giorgio Amato, Daiana Giannini, Silvia Bilia, Francesco Masini, Greta Pellegrino, Erika Pigatto, Elena Generali, Giuseppa Pagano Mariano, Giorgio Pettiti, Giovanni Zanframundo, Raffaele Brittelli, Vincenzo Aiello, Rodolfo Caminiti, Daniela Scorpiniti, Tommaso Ferrari, Corrado Campochiaro, Veronica Brusi, Micaela Fredi, Liala Moschetti, Fabio Cacciapaglia, Sabrina Rosaria Paparo, Francesca Ragusa, Valeria Mazzi, Giusy Elia, Silvia Martina Ferrari, Ilenia Di Cola, Marta Vadacca, Sebastiano Lorusso, Monica Monti, Serena Lorini, Maria Letizia Aprile, Marco Tasso, Mario Miccoli, Silvia Bosello, Salvatore D'Angelo, Andrea Doria, Franco Franceschini, Riccardo Meliconi, Marco Matucci-Cerinic, Florenzo Iannone, Roberto Giacomelli, Carlo Salvarani, Anna Linda Zignego, Poupak Fallahi, Alessandro Antonelli |
48 |
[GO] |
2022―Jun―07 |
Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part V) |
Mohammad Amjad Kamal, Md Asaduzzaman Khan |
49 |
[GO] |
2022―May―27 |
Main Diagnostic Methods for Covid-19: Integrative Review |
Ana Sara Martins de Campos, Giandra Azolini Fernandes de Souza, Renan Almeida de Jesus, Giuliana Zardeto, Guilherme Donadel, Mariana Dalmagro, et al. (+7) Jéssica Renata de Almeida Canoff, Jaqueline Hoscheid, Odair Alberton, Daniela de Cássia Faglioni Boleta-Ceranto, Daniela Dib Gonçalves, Emerson Luiz Botelho Lourenço, Juliana Cogo |
50 |
[GO] |
2022―May―22 |
Immunopathogenesis and immunogenetic variants in COVID-19 |
Pakorn Sagulkoo, Kitiporn Plaimas, Apichat Suratanee, Andrea Name Colado Simão, Edna Maria Vissoci Reiche, Michael Maes |
51 |
[GO] |
2022―May―07 |
Can we s쳮d in the fight against SARS-CoV-2 with its emerging new variants? |
Shima Tavakol, Hani Tavakol, Mo S. Alavijeh, Alexander Seifalian |
52 |
[GO] |
2022―Apr―30 |
Repositioning therapeutics for SARS-CoV-2: Virtual screening of plant-based Anti-HIV compounds as possible inhibitors against COVID-19 viral RdRp |
Mahadevamurthy Murali, Hittanahallikoppal Gajendramurthy Gowtham, Mohammad Azam Ansari, Mohammad N. Alomary, Saad Alghamdi, Mazen Almehmadi, et al. (+6) Sudarshana Brijesh Singh, Natarajamurthy Shilpa, Mohammed Aiyaz, Nataraj Kalegowda, Ana E. Ledesma, Kestur Nagaraj Amruthesh |
53 |
[GO] |
2022―Apr―20 |
Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature |
Jimmy T. Efird, Ethan Anderson, Charulata Jindal, Ayako Suzuki |
54 |
[GO] |
2022―Mar―29 |
Ivabradine in the management of COVID-19-related cardiovascular complications: A perspective |
Tomas Baka, Kristina Repova, Ivan Luptak, Fedor Simko |
55 |
[GO] |
2022―Mar―23 |
Alterations in clinical characteristics of blood donors post COVID-19 recovery |
Fahad Al Ghamdi, Salma Naqvi, Fahad A. Alabassi, Sultan Alhayyani, Mirza Rafi Baig, Vikas Kumar, Firoz Anwar |
56 |
[GO] |
2021―Dec―13 |
A review of the rational and current evidence on colchicine for COVID-19 |
Hazem S. Ghaith, Mohamed Diaa Gabra, Mohamed H. Nafady, Hamza Emad Elshawah, Ahmed Negida, Mohammad Amjad Kamal |
57 |
[GO] |
2021―Oct―22 |
Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part IV) |
Md Asaduzzaman Khan, Mohammad Amjad Kamal |
58 |
[GO] |
2021―Oct―21 |
Covid-19 Epidemiology, Pathogenesis and Therapy |
Alessandro Antonelli, Clodoveo Ferri |
59 |
[GO] |
2021―Oct―14 |
Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part III) |
Md Asaduzzaman Khan, Mohammad Amjad Kamal |
60 |
[GO] |
2021―Sep―03 |
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments |
Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Massimo L’Andolina, Lorenzo Dagna, Antonio Tavoni, et al. (+79) Francesco Caso, Francesco Ursini, Ruscitti Piero, Maurizio Caminiti, Rosario Foti, Valeria Riccieri, Serena Guiducci, Roberta Pellegrini, Elisabetta Zanatta, Giuseppe Varcasia, Domenico Olivo, Pietro Gigliotti, Giovanna Cuomo, Giuseppe Murdaca, Riccardo Cecchetti, Rossella De Angelis, Nicoletta Romeo, Francesca Ingegnoli, Franco Cozzi, Veronica Codullo, Ilaria Cavazzana, Michele Colaci, Giuseppina Abignano, Maria De Santis, Ennio Lubrano, Enrico Fusaro, Alessandra Della Rossa, Amelia Spinella, Federica Lumetti, Giacomo De Luca, Silvia Bellando-Randone, Elisa Visalli, Ylenia Dal Bosco, Giorgio Amato, Daiana Giannini, Silvia Bilia, Francesco Masini, Greta Pellegrino, Erika Pigatto, Elena Generali, Giuseppa Pagano Mariano, Giorgio Pettiti, Giovanni Zanframundo, Raffaele Brittelli, Vincenzo Aiello, Rodolfo Caminiti, Daniela Scorpiniti, Tommaso Ferrari, Corrado Campochiaro, Veronica Brusi, Micaela Fredi, Liala Moschetti, Fabio Cacciapaglia, Laura Gragnani, Monica Monti, Serena Lorini, Sabrina Rosaria Paparo, Francesca Ragusa, Valeria Mazzi, Giusy Elia, Silvia Martina Ferrari, Ilenia Di Cola, Marta Vadacca, Sebastiano Lorusso, Simone Barsotti, Maria Letizia Aprile, Tasso Marco, Mario Miccoli, Silvia Bosello, Marco Matucci-Cerinic, Salvatore D'Angelo, Andrea Doria, Franco Franceschini, Riccardo Meliconi, Florenzo Iannone, Roberto Giacomelli, Anna Linda Zignego, Poupak Varcasia, Alessandro Antonelli |
61 |
[GO] |
2021―Sep―01 |
Nanotechnology-Based Strategies for the Management of COVID-19: Recent Development and Challenges |
Ritu Singh, Monalisha Behera, Nisha Kumari, Sanjeev Kumar, Vishnu D. Rajput, Tatiana M Minkina, et al. (+3) Mohd Adnan, Arif Jamal Siddiqui, Narendra Kumar |
62 |
[GO] |
2021―Sep―01 |
The Use of Lectins as Tools to Combat SARS-CoV-2 |
Daniela Martinez, Diego Amaral, David Markovitz, Luciano Pinto |
63 |
[GO] |
2021―Jul―16 |
Synopsis on Pharmotechnological Approaches in Diagnostic to Management Strategies in Fighting Against COVID-19 |
Asim Azhar, Nazia Hassan, Manvi Singh, Khaled Al-hosaini, Mohammad Amjad Kamal |
64 |
[GO] |
2021―Jul―06 |
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
Khojasteh Malekmohammad, Mahmoud Rafieian-Kopaei |
65 |
[GO] |
2021―Jul―05 |
Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19 |
Md. Mominur Rahman, Muniruddin Ahmed, Mohammad Touhidul Islam, Md. Robin Khan, Sharifa Sultana, Saila Kabir Maeesa, et al. (+6) Sakib Hasan, Md. Abid Hossain, Kazi Sayma Ferdous, Bijo Mathew, Abdur Rauf, Md. Sahab Uddin |
66 |
[GO] |
2021―Jun―10 |
Different Methods for Molecular and Rapid Detection of Human Novel Coronavirus |
Mohamad Hesam Shahrajabian, Wenli Sun, Qi Cheng |
67 |
[GO] |
2021―Jun―09 |
The roles of vitamin D in increasing the body's immunity and reducing injuries due to viral infections: With an emphasis on its possible role in SARS-CoV-2 (COVID-19) |
Elahe Aleebrahim-Dehkordi, Niloofar Deravi, Shirin Yaghoobpoor, Dariush Hooshyar, Mahmoud Rafieian-Kopaei |
68 |
[GO] |
2021―May―22 |
Preventive and Therapeutic Strategies to Fight COVID-19 |
Alexander Marcus Seifalian, Shima Tavakol |
69 |
[GO] |
2021―Mar―24 |
Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II) |
Md Asaduzzaman Khan, Mohammad Amjad Kamal |
70 |
[GO] |
2021―Mar―16 |
Tocilizumab: From Rheumatic Diseases to Covid-19 |
Alberto Raiteri, Fabio Piscaglia, Alessandro Granito, Francesco Tovoli |
71 |
[GO] |
2021―Mar―03 |
Identification of the interaction between Angiotensin-converting Enzyme Residues and Severe Acute Respiratory Syndrome Coronavirus 2. |
Youness Kadil, Mohammed Mouhcine, Imane Rahmoune, Houda Filali |
72 |
[GO] |
2021―Mar―03 |
Diabetes and COVID-19; a review of possible mechanisms |
Reyhaneh Moradi-Marjaneh, Fereshteh Asgharzadeh, Elnaz Khordad, Mahdi Moradi Marjaneh |
73 |
[GO] |
2021―Feb―25 |
COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact |
Saimon Shahriar, Md. Sohel Rana, Md. Sabbir Hossain, Ariful Karim, Tasneem Nayla Mredula, Nadia Nourin, et al. (+2) Md. Sahab Uddin, Md. Shah Amran |
74 |
[GO] |
2021―Feb―23 |
The association of respiratory viruses with oxidative stress and antioxidants. Implications for the COVID-19 pandemic |
Marina Darenskaya, Liubov Kolesnikova, Sergei Kolesnikov |
75 |
[GO] |
2021―Feb―04 |
Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19 |
Pallavi Singh Chauhan, Dhananjay Yadav, Anuj Dubey, Jun-O Jin |
76 |
[GO] |
2021―Jan―26 |
The computational intervention of macrolide antibiotics in the treatment of COVID-19 |
Firoz Anwar, Hisham N. Altayb, Fahad A. Al-Abbasi, Vikas Kumar, Mohammad Amjad Kamal |
77 |
[GO] |
2021―Jan―26 |
Emerging therapeutic approaches to COVID-19 |
Indrakant Kumar Singh, Pratibha Kumari, Pooja Mittal, Amit Kumar, Bharti Singal, Gulam Mustafa Hasan, et al. (+4) Rajiv Aggarwal, Mohammad Amjad Kamal, Archana Singh, Imtaiyaz Hassan |
78 |
[GO] |
2021―Jan―18 |
Therapeutic agents against COVID-19 with clinical evidence |
Cheng Tian, Ming Xiang |
79 |
[GO] |
2021―Jan―18 |
Natural agents modulating ACE-2: A review of compounds with potential against SARS-CoV-2 infections |
Arquimedes Gasparotto Junior, Sara Emília Lima Tolouei, Francislaine Aparecida dos Reis Lívero, Francielli Gasparotto, Thaise Boeing, Priscila de Souza |
80 |
[GO] |
2021―Jan―12 |
In silico Prediction and Designing of Potential siRNAs to be Used as Antivirals Against SARS-CoV-2 |
Sayed Sartaj Sohrab, Sherif Aly El-Kafrawy, Aymn T. Abbas, Leena H. Bajrai, Esam Ibraheem Azhar |
81 |
[GO] |
2021―Jan―12 |
Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical based Evidence |
Ashif Iqubal, Mohammad Kashif Iqubal, Musheer Ahmed, Syed Ehtaishamul Haque |
82 |
[GO] |
2021―Jan―04 |
COVID-19: An Update on Pathogenesis and Treatment |
Marwa Abduallah AL Dhamen, Abrar Fouad Alhashim, Hawra Hussain Alqattan, Faheem Hyder Pottoo |
83 |
[GO] |
2021―Jan―04 |
Emergence and Reemergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target |
Fahim Ahmad, Mohammad A. Kamal, Babu L. Tekwani |
84 |
[GO] |
2021―Jan―03 |
Use of Natural Compounds as a potential therapeutic agent against COVID-19 |
Shadma Wahab, Irfan Ahmad, Safia Irfan, Mohammad Hassan Baig, Abd-ElAziem Farouk, Jae-Jun Dong |
85 |
[GO] |
2020―Dec―24 |
In silico studies reveal antiviral effects of traditional Indian spices on COVID-19 |
Brijesh Kumar, Sama Zaidi, Shafiul Haque, Nandita Dasgupta, Arif Hussain, Sreepoorna Unni, et al. (+2) Vineeta Singh, Bhartendu Nath Mishra |
86 |
[GO] |
2020―Dec―23 |
A Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management |
Hussien Ahmed, Ahmed Sayed, Malak Munir, Mostafa H. Elberry, Ibrahim M Sayed, Mohammed Amjad Kamal, et al. (+3) Ahmed Negida, Mahmoud Ahmed Ebada, Eshak I. Bahbah |
87 |
[GO] |
2020―Dec―14 |
An Overview of Natural and Synthetic Analogs of Quinoline for the Prophylaxis of COVID-19. Chloroquine Analogs: An Overview of Natural and Synthetic Quinolines as Broad Spectrum Antiviral Agents |
Veera Bramhachari Pallaval, Manasa Kanithi, Sangeetha Meenakshisundaram, Achanta Jagadeesh, Mattareddy Alavala, Thanigaimalai Pillaiyar, et al. (+2) Manoj Manickam, Bojjibabu Chidipi |
88 |
[GO] |
2020―Dec―11 |
Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence |
Simone Ronsisvalle, Federica Panarello, Rosaria Di Mauro, Renato Bernardini, Giovanni Li Volti, Giuseppina Cantarella |
89 |
[GO] |
2020―Dec―11 |
Silybin B and Cianidanol Inhibit M pro and Spike Protein of SARS-CoV-2: Evidence from in Silico Molecular Docking Studies |
Rashi Srivastava, Shubham Tripathi, Sreepoorna Unni, Arif Hussain, Shafiul Haque, Nandita Dasgupta, et al. (+2) Vineeta Singh, Bhartendu Nath Mishra |
90 |
[GO] |
2020―Dec―05 |
COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review |
Ayesha Aziz, Muhammad Asif, Ghazala Ashraf, Qiaoli Yang, Shenqi Wang |
91 |
[GO] |
2020―Dec―03 |
Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A new Route to Fight against COVID-19? |
Shah Khalid, Faisal A. Almalki, Taibi Ben Hadda, Ammar Bader, Tareq Abu-Izneid, Malika Berredjem, et al. (+2) Eman R. Elsharkawy, Ali M . Alqahtani |
92 |
[GO] |
2020―Nov―30 |
Viral Diseases and Natural Products: Prospects in COVID-19 Treatment |
Mohammad Amjad Kamal, Md Asaduzzaman Khan |
93 |
[GO] |
2020―Nov―26 |
Therapeutic management of COVID-19 patients: Clinical manifestation and limitations |
Urooj Fatima, Syed Saif Abbas Rizvi, Neha Raina, Saher Fatima, Safikur Rahman, Mohammad Amjad Kamal, Md. Imtaiyaz Hassan |
94 |
[GO] |
2020―Nov―26 |
Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm |
Monireh Torabi-Rahvar, Nima Rezaei |
95 |
[GO] |
2020―Nov―20 |
Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19 |
Yasanandana Supunsiri Wijayasinghe, Pravin Bhansali, Ronald E. Viola, Mohammad A. Kamal, Nitesh Kumar Poddar |
96 |
[GO] |
2020―Nov―20 |
Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19 |
Md Tabish Rehman, Mohamed F. AlAjmi, Afzal Hussain |
97 |
[GO] |
2020―Nov―20 |
COVID-19 and domestic animals: Exploring the species barrier crossing, zoonotic and reverse zoonotic transmission of SARS-CoV-2 |
Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Mehboobali Paninipara, Tapan Behl, Githa Elizabeth Mathew, Bijo Mathew |
98 |
[GO] |
2020―Nov―20 |
Coronavirus Disease -2019 (COVID-19) in 2020: A Perspective Study of a Global Pandemic |
Mujtaba Aamir Bhat, Safikur Rahman, Irfan Ahmad Rather, Iqbal Banday, Shafiya Syed, Hamira Koser, et al. (+3) Mohammad Amjad Kamal, Rinki Minakshi, Arif Tasleem Jan |
99 |
[GO] |
2020―Nov―20 |
The impact of traditional plants and their secondary metabolites in the discovery of COVID-19 treatment |
Shabana Bibi, Ayesha Sarfraz, Ghazala Mustafa, Zeeshan Ahmed, Muhammad Aurang Zeb, Yuan-Bing Wang, et al. (+4) Tahir Khan, Muhammad Saad Khan, Mohammad Amjad Kamal, Hong Yu |
100 |
[GO] |
2020―Nov―06 |
Current landscape of natural products against coronaviruses: perspectives in COVID-19 treatment and antiviral mechanism |
Jakaria Shawon, Zakia Akter, Md. Munnaf Hossen, Yeasmin Akter, Abu Sayeed, Md Junaid, et al. (+2) Syeda Samira Afrose, Md Asaduzzaman Khan |
101 |
[GO] |
2020―Nov―06 |
Properties of Ethno-Medicinal Plants and Their Bioactives-Possible Use for Prevention and Treatment of COVID-19: A Review |
Ambreen Shoaib, Lubna Azmi, Ila Shukla, Saad S. Alqahtani, Ibrahim A. Alsarra, Faiyaz Shakeel |
102 |
[GO] |
2020―Oct―26 |
COVID-19 Vaccines on Clinical Trials and their Mode of Action for Immunity against the Virus |
Shima Tavakol, Mo S. Alavijeh, Alexander M. Seifalian |
103 |
[GO] |
2020―Oct―16 |
The undiscovered potential of essential oils for treating SARS-CoV-2 (COVID- 19) |
Peter J. Wilkin, Minnatallah Al-Yozbaki, Alex George, Girish Kumar Gupta, Cornelia M. Wilson |
104 |
[GO] |
2020―Oct―02 |
miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis |
Rohit Satyam, Tulika Bhardwaj, Sachin Goel, Niraj Kumar Jha, Saurabh Kumar Jha, Parma Nand, et al. (+3) Janne Ruokolainen, Mohammad Amjad Kamal, Kavindra Kumar Kesari |
105 |
[GO] |
2020―Oct―01 |
Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients |
Kholoud F. Aliter, Rami A. Al-Horani |
106 |
[GO] |
2020―Sep―11 |
Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts’ Cell |
Debmalya Roy, Ipshita Khanra, Zeling Wang, Siva Bharath Merugu, Fakhar-un-Nisa Yunus, Dhahiri Saidi Mashausi, Dawei Li |
107 |
[GO] |
2020―Sep―03 |
Targeting Natural Products for the Treatment of COVID-19 - An Updated Review |
Ramachandra Reddy Pamuru, Naveen Ponneri, Amooru G Damu, Ramakrishna Vadde |
108 |
[GO] |
2020―Aug―26 |
Emergence of human pathogenic Coronaviruses: Lectins as antivirals for SARS-CoV-2 |
Sayed Sartaj Sohrab, Mohd Suhail, Mohammad Amjad Kamal, Fahim Ahmad, Esam Ibraheem Azhar |
109 |
[GO] |
2020―Aug―26 |
Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multi Layered High Throughput Virtual Screening Approach |
Anupam Dhasmana, Vivek Kumar Kashyap, Swati Dhasmana, Sudhir Kotnala, Shafiul Haque, Ghulam Md Ashraf, et al. (+3) Meena Jaggi, Murali M. Yallapu, Subhash C. Chauhan |
110 |
[GO] |
2020―Aug―19 |
Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective |
Freah Alshammary, Ammar Ahmed Siddiqui, Junaid Amin, Muhammad Ilyas, Hassaan Anwer Rathore, Ibne Hassan, et al. (+2) Mohammad Khursheed Alam, Mohammad Amjad Kamal |
111 |
[GO] |
2020―Aug―13 |
Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the “Cytokine Release (Storm) Syndrome” Caused by SARS-CoV-2? |
Francisco José López-Iranzo, Ana María López-Rodas, Luis Franco, Gerardo López-Rodas |
112 |
[GO] |
2020―Jul―22 |
A Case Study: Analysis of Patents of Coronaviruses and Covid-19 for Technology Assesment and Future Research |
Pankaj Musyuni, Geeta Aggarwal, Manju Nagpal, Ramesh K. Goyal |
113 |
[GO] |
2020―Jul―14 |
Current Status of the COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy |
Tapan Behl, Md. Habibur Rahman, Rokeya Akter, Md. Arifur Rahman Chowdhury, Manirujjaman Mohammed, Israt Jahan Bulbul, et al. (+2) Shimaa E. Elshenawyand, Mohammad Amjad Kamal |
114 |
[GO] |
2020―Jul―07 |
Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19) |
Evellyn Claudia Wietzikoski Lovato, Lorena Neris Barboza, Samantha Wietzikoski, Amanda Nascimento Vasques de Souza, Pablo Alvarez Auth, Arquimedes Gasparotto Junior, Francislaine Aparecida dos Reis Lívero |